The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...

MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...

Tempur-Pedic Bed Bases manufactures adjustable bed bases. The company's beds offer features like wireless remote controls, zero-gravity presets and lumbar support. Tempur-Pedic combines its adjustable ...